We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Smoking Cessation for Smokers With Sleep Problems

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01277887
First Posted: January 17, 2011
Last Update Posted: October 12, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
Lisa M. Fucito, Yale University
January 13, 2011
January 17, 2011
October 12, 2017
December 2010
March 2012   (Final data collection date for primary outcome measure)
Smoking Abstinence [ Time Frame: 1 Week ]
To develop effect size estimates for smoking cessation defined as point prevalence smoking abstinence over the last 7 days of treatment and follow-up (i.e., 4 weeks post-treatment) comparing smokers in the two counseling conditions.
Same as current
Complete list of historical versions of study NCT01277887 on ClinicalTrials.gov Archive Site
  • Self-Control to Resist Smoking Cues [ Time Frame: 4 Weeks ]
    To develop an effect size estimate for changes in self-control to resist smoking cues from baseline to the day before quitting smoking comparing smokers in the two counseling conditions.
  • Sleep Efficiency [ Time Frame: 10 weeks ]
    To develop an effect size estimate for changes in diary measures of sleep efficiency over the entire treatment period comparing smokers in the two counseling conditions.
Same as current
Not Provided
Not Provided
 
Smoking Cessation for Smokers With Sleep Problems
Smoking Cessation for Smokers With Sleep Problems
This is a pilot research study examining two types of behavioral counseling along with the nicotine patch for smoking cessation. The study is designed to find out whether one of these counseling interventions is more effective for smoking cessation among individuals with sleep problems. The study has three parts: 1) an intake session; 2) a 10-week treatment phase, and 3) a 1-month follow-up.
This is a developmental study to: 1) create and test an integrated cognitive-behavioral smoking cessation and insomnia intervention with 30 smokers who report current insomnia. Participants are randomized to 1 of 2 counseling conditions. The cognitive-behavioral intervention provides standard care smoking counseling along with counseling to address insomnia. The smoking counseling intervention provides standard care smoking counseling adapted from the American Lung Association Freedom from Smoking program. Efficacy data from this trial will be used to determine effect size estimates for biologically confirmed self-reported point prevalence smoking abstinence at the end of treatment and 1 month after completing treatment. Changes in sleep efficiency and self-control to resist smoking urges will also be examined. If the effect size estimates are sufficiently large and medically important to pursue a definitive trial, these data will be used to propose a full scale large study.
Interventional
Early Phase 1
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Outcomes Assessor)
Primary Purpose: Treatment
  • Nicotine Dependence
  • Cigarette Smoking
  • Insomnia
  • Behavioral: Cognitive-Behavioral Counseling
    The cognitive-behavioral intervention integrates standard smoking counseling adapted from the American Lung Association Freedom from Smoking program along with cognitive-behavioral techniques for improving insomnia.
    Other Name: CBT-I + SC
  • Behavioral: Smoking Cessation Counseling
    The smoking cessation counseling intervention will incorporate standard psychoeducational and behavioral smoking counseling techniques adapted from the American Lung Association Freedom from Smoking program.
    Other Name: SC
  • Active Comparator: Cognitive-Behavioral Counseling
    The intervention consists of 8 sessions provided over 10 weeks. Counseling commences 4 weeks before quitting smoking. Participants will also receive the nicotine patch for 6 weeks starting on the day of quit date.
    Intervention: Behavioral: Cognitive-Behavioral Counseling
  • Placebo Comparator: Smoking Cessation Counseling
    The intervention consists of 8 sessions provided over 10 weeks. Counseling commences 4 weeks before quitting smoking. Participants will also receive the nicotine patch for 6 weeks starting on the day of quit date.
    Intervention: Behavioral: Smoking Cessation Counseling
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
19
March 2012
March 2012   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Between the ages of 18 and 75.
  • Smoking 10 or more cigarettes per day for at least 1 year.
  • An expired air breath carbon monoxide level > 10 ppm.
  • Motivated to stop smoking.
  • Understand English.
  • Meet DSM-IV criteria for insomnia.
  • Report sleep latency or waking after sleep onset >30 minutes on ≥6 occasions within past month.

Exclusion Criteria:

  • History of allergic reactions to adhesives.
  • Unstable psychiatric/medical conditions such as current suicidal or homicidal ideation, acute psychosis, dementia.
  • Have a current diagnosis of DSM-IV alcohol or drug dependence other than nicotine.
  • Use of tobacco products other than cigarettes or use of marijuana.
  • Intention to use nicotine replacement therapy, varenicline, or bupropion during study participation.
  • Females of childbearing potential who are pregnant, nursing, or not practicing effective contraception (oral, injectable, or implantable contraceptives, intrauterine device, or barrier method with spermicide).
  • New onset of psychiatric disorders or new psychotropic medications within the past 3 months.
  • Inability to read/understand English.
  • History of sleep apnea based on responses to Berlin Questionnaire.
  • History of restless leg syndrome.
  • Current night or rotating shift work.
  • Proposed travel across 2 or more time zones during study participation.
  • Medical/psychiatric conditions contraindicated for sleep restriction (i.e., seizure disorders, severe excessive daytime sleepiness - Epworth Scale >18, and bipolar disorder).
Sexes Eligible for Study: All
18 Years to 75 Years   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT01277887
NCT009241
P50DA009241-16 ( U.S. NIH Grant/Contract )
Yes
Not Provided
Not Provided
Lisa M. Fucito, Yale University
Yale University
National Institute on Drug Abuse (NIDA)
Principal Investigator: Lisa Fucito, PhD Yale University
Yale University
June 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP